Searched for
MEDICINES SANS FRONTIERS
What to know about the outbreak of a rare kind of Ebola as cases outpace responseA rare Ebola outbreak is spreading rapidly in Congo and Uganda. The Bundibugyo virus has no approved treatments. Health workers face challe...- Acquisition count rises: Inside OpenAI's major deals in 2026The AI major’s half a dozen deals in the first quarter underscore its push to strengthen its position across enterprise software, developer...
- Anthropic appoints Indian-origin Novartis CEO Vas Narasimhan to its boardAnthropic’s Long-Term Benefit Trust is an independent governance body, designed to insulate key decisions as it scales its frontier AI syst...
- Govt widens composition of drug, medical devices pricing reforms panelThe government has expanded a committee to look into pricing reforms for drugs and medical devices, including civil rights activists like A...
- UK officials pressured to drop IP demands in India trade talkThe leaked documents from negotiations show that the UK wants India to tighten its IP laws in the free trade agreement under negotiation.
- Medicine Sans Frontiers: India is gearing up to grab a larger pie of $80-bn medical tourism marketWhat is unusual though is that this time, the Government of India (GoI) has picked a niche: it is now focusing more on medical tourism, a s...
- Civil bodies call for a real TRIPS waiverThe groups requested governments to adopt a real TRIPS waiver that would adequately address intellectual property on all essential Covid-19...
- Attackers kill 88 people in northwest NigeriaPerpetrators swept through eight villages, killing people and sending residents fleeing, police said, giving a death toll of 88. Details be...
- Johnson and Johnson asked to cut down price of new TB drugTo ensure the drug is accessible to all, MSF called on J&J to issue a non-exclusive license to the Medicines Patent Pool to allow for price...
- Hospitals face HIV testing kits' shortageThe reason for the shortage is not a paucity of funds but delay by the NACO in placing tenders for procurement, experts said.
- New compulsory licences policy raises monopoly concernsThe Department of Pharmaceutical floated the draft policy on price negotiations for patented drugs in an attempt to regulate the highly-pri...
- Government suggests doing away with Compulsory License on the basis of priceDOP in the new draft policy said that once patented drugs are regulated, the provision to issue Compulsory License will not be possible
- Supreme Court defers Novartis' patent appeal to September 11Supreme Court on Wednesday deferred Swiss company Novartis' case against Indian government over the interpretation of Section 3 (d) of the ...
- Activists protest India-EU trade dealA group of activists staged a demonstraton here to protest against EU-India trade deal which they allege have a severe negative impact.
- EU pact won’t hurt genericsThe proposed India-EU trade and investment agreement will not curtail India’s right to produce and export cheap life-saving medicines.
- MSF welcomes India's decision to reject drug patent to Roche'Medicins Sans Frontieres', an international medical humanitarian group, today welcomed India's decision to reject a patent granted to Swis...
- Govt won't tweak drug patent rulesEarlier this month, the ministry accepted the controversial report, first released in 2007 but withdrawn over allegations of plagiarism and...
- Protest over govt-funded pharma R&D incentive BillGovt’s plan to boost research and development using public funds has raised sharp reactions from public interest groups on the commercial r...
- US backed India on Glivec patentA day after the Madras High Court struck down the petition of pharma giant Novartis on Glivec, civil society organisations, including Medec...
- Novartis urged not to appeal Indian patent rulingThe humanitarian group Medecins Sans Frontieres (MSF, Doctors Without Borders) on Wednesday urged Swiss pharmaceutical group Novartis not t...
Load More
